In this report, clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. Market, on basis of product and service, is segmented into software and services. The globe is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Learn details of the Company Profiles, Future Trends and Complete Overview
- Agency -.
The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region. Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging.
Asia is expected to grow at the highest CAGR in the forecast period.
Complete report on Clinical Trial Imaging Market spread across 123 Pages, Profiling 11 Companies and supported with 158 Tables and 31 Figures is now available at www.rnrmarketresearch.com/clinical-trial-imaging-market-by-product-services-software-modality-ct-mri-pet-ultrasound-echocardiography-x-ray-end-user-pharmaceutical-companies-biotechnology-companies-cros-medical-device-manufac-st-to-2021-market-report.html .
- Agency -.
Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the highest CAGR in the forecast period.
The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region. On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities.
In 2016, the CT segment is expected to account for the largest share of the global clinical trial imaging market.
- Medical Device Industries
- Academic and Government Research Institutes
- Diagnostic Centers
- Market Research & Consulting Firms
- Clinical Trial Imaging Manufacturers, Vendors, and Distributors
- Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROs)
Increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the clinical trial imaging market.
It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in last three years.
The company profiles comprise basic views on key players in clinical trial imaging market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in near future.
The clinical trial imaging market is dominated by established players such as BioClinica, Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.).
The growth in Asian market is driven by growth in pharmaceutical & biotechnology industries and increase in R&D spending in region. This research study involved extensive usage of both primary and secondary data sources as well as various factors affecting industry, including regulatory landscape; competitive scenario; historic data; current trends in market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: